E. Stumpf

572 total citations
14 papers, 370 citations indexed

About

E. Stumpf is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, E. Stumpf has authored 14 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Gastroenterology. Recurrent topics in E. Stumpf's work include Gastric Cancer Management and Outcomes (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). E. Stumpf is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). E. Stumpf collaborates with scholars based in Germany and United States. E. Stumpf's co-authors include F. A. Anderer, Rainer Fischer, H. J. Staab, T. Brümmendorf, K. Maier, Ulrich Klotz, Christine Fischer and Kelly Goodwin and has published in prestigious journals such as British Journal of Cancer, The American Journal of Surgery and Journal of Molecular Medicine.

In The Last Decade

E. Stumpf

12 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Stumpf Germany	8	257	128	88	69	59	14	370
Nicholas J. Petrelli United States	8	325 1.3×	88 0.7×	89 1.0×	164 2.4×	16 0.3×	18	446
Robert Goslin United States	5	306 1.2×	111 0.9×	126 1.4×	75 1.1×	54 0.9×	5	411
Frank J. Panettiere United States	11	225 0.9×	114 0.9×	100 1.1×	76 1.1×	8 0.1×	21	371
J. C. Leonard United Kingdom	11	173 0.7×	65 0.5×	62 0.7×	18 0.3×	79 1.3×	15	322
Marco Stella Italy	9	219 0.9×	102 0.8×	162 1.8×	33 0.5×	58 1.0×	19	464
Geoff Chong Australia	9	274 1.1×	117 0.9×	105 1.2×	111 1.6×	31 0.5×	25	414
H. Al‐Abadi Germany	10	137 0.5×	144 1.1×	147 1.7×	19 0.3×	20 0.3×	24	326
Howard E. Lessner United States	8	156 0.6×	82 0.6×	53 0.6×	100 1.4×	19 0.3×	9	374
Etsuji Shimada Japan	9	236 0.9×	70 0.5×	109 1.2×	61 0.9×	35 0.6×	24	457
Hae‐Ran Yun South Korea	11	427 1.7×	155 1.2×	250 2.8×	119 1.7×	23 0.4×	17	524

Countries citing papers authored by E. Stumpf

Since Specialization

Citations

This map shows the geographic impact of E. Stumpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Stumpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Stumpf more than expected).

Fields of papers citing papers by E. Stumpf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Stumpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Stumpf. The network helps show where E. Stumpf may publish in the future.

Co-authorship network of co-authors of E. Stumpf

This figure shows the co-authorship network connecting the top 25 collaborators of E. Stumpf. A scholar is included among the top collaborators of E. Stumpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Stumpf. E. Stumpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Goodwin, Kelly, et al.. (2024). Optimizing Treatment of BRAF V600E–Mutant Metastatic NSCLC With Encorafenib and Binimetinib: A Practical Resource for Advanced Practice Providers. Journal of the Advanced Practitioner in Oncology. 15(8). 1–17.

Staab, H. J., et al.. (1985). Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. The American Journal of Surgery. 149(2). 198–204. 69 indexed citations

Brümmendorf, T., et al.. (1985). Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. Journal of Surgical Oncology. 28(4). 263–269. 6 indexed citations

Fischer, Christine, et al.. (1983). Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man. European Journal of Clinical Pharmacology. 25(4). 511–515. 33 indexed citations

Anderer, F. A., et al.. (1982). Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer. British Journal of Cancer. 46(5). 773–781. 45 indexed citations

Anderer, F. A., et al.. (1981). Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma. British Journal of Cancer. 44(5). 652–662. 49 indexed citations

Staab, H. J., F. A. Anderer, E. Stumpf, & Rainer Fischer. (1980). Rezidivprognosen bei Patienten mit Adenocarcinomen des Gastrointestinaltraktes auf der Basis von Carcinoembryonalem Antigen (CEA) und seinen zirkulierenden Immunkomplexen. Journal of Molecular Medicine. 58(3). 125–133. 5 indexed citations

Anderer, F. A., et al.. (1980). Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract?. British Journal of Cancer. 42(1). 26–33. 20 indexed citations

Staab, H. J., F. A. Anderer, E. Stumpf, & Rainer Fischer. (1980). Die prognostische Bedeutung von zirkulierenden Immunkomplexen des Carcinoembryonalen Antigens (CEA) bei Patienten mit Adenokarzinomen des Gastrointestinaltraktes. Clinical Chemistry and Laboratory Medicine (CCLM). 18(3). 175–182. 1 indexed citations

10.

Staab, H. J., F. A. Anderer, E. Stumpf, & Rainer Fischer. (1978). Carcinoembryonic antigen follow‐up and selection of patients for second‐look operation in management of gastrointestinal carcinoma. Journal of Surgical Oncology. 10(3). 273–282. 37 indexed citations

11.

Staab, H. J., F. A. Anderer, E. Stumpf, & Rainer Fischer. (1978). Postoperative Differentiation of Local Tumor Recurrence and Generalized Metastasizing in Patients with Adenocarcinomas of the Digestive System by CEA Follow‐up Study. Scandinavian Journal of Immunology. 8(s8). 459–464. 3 indexed citations

12.

Staab, H. J., F. A. Anderer, E. Stumpf, & Rainer Fischer. (1978). Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. The American Journal of Surgery. 136(3). 322–327. 90 indexed citations

13.

Staab, H. J., F. A. Anderer, E. Stumpf, & Rainer Fischer. (1977). Carcinoembryonales Antigen (CEA). DMW - Deutsche Medizinische Wochenschrift. 102(30). 1082–1086. 11 indexed citations

14.

Stumpf, E., et al.. (1976). [Computer-supported postoperative CEA-course controls : correlation with the prognosis of recurrence and findings of second-look operations].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 85–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact